P-104 Outcomes by IPSS-R in lenalidomide-treated patients with IPSS low-/Int-1-risk MDS With del(5q) in MDS-003 and MDS-004: A retrospective analysis

Journal article

Peer reviewed

M. Sekeres, A. Swern, P. Fenaux, P. Greenberg, G. Sanz, J. Bennett, F. Dreyfus, M. Cazzola, A. List, G. Garcia-Manero, …

Leukemia research, Vol.37, pp.S69-S70

2013-05

Metrics

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.155 Acute Myeloid Leukemia
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: P-104 Outcomes by IPSS-R in lenalidomide-treated patients with IPSS low-/Int-1-risk MDS With del(5q) in MDS-003 and MDS-004: A retrospective analysis
Creators: M. Sekeres
A. Swern
P. Fenaux
P. Greenberg
G. Sanz
J. Bennett
F. Dreyfus
M. Cazzola
A. List
G. Garcia-Manero
J. Shiansong Li
M. Sugrue
Publication Details: Leukemia research, Vol.37, pp.S69-S70
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757853002976